Skip to search formSkip to main contentSkip to account menu

budralazine

Known as: 1(2H)-Phthalazinone, (1,3-dimethyl-2-butenylidene)hydrazone, 1-(2-(1,3-dimethyl-2-butenylidene)hydrazino)phthalazine, 4-Methyl-3-penten-2-one (1-phthalazinyl)hydrazone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
The effects of antihypertensive drugs on ischemic cerebral damage were investigated using the bilateral carotid artery occlusion… 
1989
1989
The present study was undertaken to elucidate the anti-tachycardiac effect of a direct-acting vasodilator, budralazine, using an… 
1986
1986
Cardiovascular effects of budralazine were investigated in isolated and cross-circulated dog atrial preparations. When… 
1983
1983
Intravenous injection of 1-[2-(1,3-dimethyl-2-butenylidene)hydrazino]phthalazine (budralazine) to anesthetized dogs resulted in… 
1983
1983
Vasodilator drugs have often been applied clinically to the patients with ischemic heart disease or hypertension, and their… 
1981
1981
In renal hypertensive dogs, 1-[2-(1,3-dimethyl-2-butenylidene)hydrazino]phthalazine (budralazine) at doses of 1 and 2.5 mg/kg p.o… 
1981
1981
Cardiac presynaptic and vascular postsynaptic alpha-adrenergic effects of 1-[2-(1,3-dimethyl-2-butenylidene)hydrazino]phthalazine… 
1979
1979
The synthesis of 2-(6-dialkylamino-3-pyridazinyl)hydrazinecarboxylates (II) and hydrazides (V) from the corresponding 3-chloro-6… 
1978
1978
Antihypertensive and pharmacological properties of budralazine were examined in comparison with other antihypertensive drugs…